STOCK TITAN

Nayax CLO sells 1,500 shares after option exercise

Nayax’s Chief Legal Officer exercised 1,500 options and sold the resulting shares the same day in a net sale transaction.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nayax Ltd. (NYAX) reported that Chief Legal Officer Omer Gal exercised options and sold the resulting shares on September 16, 2026. He exercised options for 1,500 Ordinary Shares at an exercise price of $21.352 per share, then sold 1,500 shares at $45.1698 per share on the Tel Aviv Stock Exchange. The options and sale prices are stated in U.S. dollars but were originally denominated in New Israeli Shekels, with the sale executed at an exchange rate of 3.033 ILS per $1.00. After the exercise, 500 options from this grant remained outstanding, and no Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider Omer Gal
Role CLO
Sold 1,500 shs ($68K)
Approx. gross sale proceeds $68K
Approx. exercise cost $32K
Approx. pre-tax spread $36K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F2, F1 1,500 $0.00 $0.00
Exercise Ordinary Shares F3, F5 1,500 $21.352 $32K
Sale Ordinary Shares F4, F6 1,500 $45.1698 $68K
Holdings After Transaction: Stock Option (Right to Buy) — 500 contracts (Direct); Ordinary Shares — 18,539 shares (Direct)
Footnotes (6)
  1. F1. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
  2. F2. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
  3. F3. The shares were acquired upon the exercise of stock options
  4. F4. The shares sold were acquired upon the exercise of stock options on the same date
  5. F5. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
  6. F6. These shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS). The exchange rate in effect on the transaction date was 3.033 ILS to $1.000 .
Options exercised 1,500 shares Ordinary Shares acquired upon option exercise on September 16, 2026
Shares sold 1,500 shares Ordinary Shares sold on September 16, 2026
Exercise price $21.352 per share Exercise price for options originally denominated in New Israeli Shekels
Sale price $45.1698 per share Price for Ordinary Shares sold on September 16, 2026
Remaining options 500 options Options from the reported grant remaining after the exercise
Exchange rate 3.033 ILS per $1.00 Rate used for the Tel Aviv Stock Exchange sale on September 16, 2026
Option expiration date November 22, 2026 Expiration date for the exercised option grant
Tel Aviv Stock Exchange market
"These shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels"
The Tel Aviv Stock Exchange is Israel’s main marketplace where stocks, bonds and exchange-traded funds are bought and sold, providing a centralized place for investors to trade ownership in companies and government debt. It matters because it sets real-time prices and liquidity for Israeli securities, offering a barometer of the country’s corporate health and giving investors a way to enter or exit positions much like an auction house or farmers’ market sets the price for goods.
New Israeli Shekels financial
"The exercise price is denominated in New Israeli Shekels"
exchange rate financial
"The exchange rate in effect on the transaction date was 3.033 ILS to $1.000"
Exchange rate is the price of one currency expressed in another—for example, how many euros you receive for one US dollar. It matters to investors because changes in that price alter the reported profits, costs and value of assets for companies and portfolios that operate or hold money across borders; think of it like switching measurement units, where the same item can look bigger or smaller depending on the unit used.
Ordinary Shares financial
"The shares were acquired upon the exercise of stock options"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Nayax (NYAX) disclose about Omer Gal’s recent equity transactions?

Nayax disclosed that Chief Legal Officer Omer Gal exercised options for 1,500 Ordinary Shares on September 16, 2026, then sold 1,500 shares the same day on the Tel Aviv Stock Exchange, resulting in a net sale of shares.

How many Nayax (NYAX) shares did Omer Gal sell and at what price?

Omer Gal sold 1,500 Ordinary Shares of Nayax at a reported price of $45.1698 per share on September 16, 2026. The sale was executed on the Tel Aviv Stock Exchange in New Israeli Shekels, using an exchange rate of 3.033 ILS per $1.00.

At what price were Omer Gal’s Nayax (NYAX) options exercised?

The options exercised by Omer Gal had an exercise price of $21.352 per share, originally denominated in New Israeli Shekels. The U.S. dollar amount reflects the exchange rate on the grant date, as disclosed in the footnotes.

How many Nayax (NYAX) options remain after Omer Gal’s exercise?

After exercising options for 1,500 shares, 500 options from the reported grant remained outstanding as of September 16, 2026, according to the post-transaction derivative holdings disclosed.

Were Omer Gal’s Nayax (NYAX) trades made under a Rule 10b5-1 plan?

No. The filing indicates that no Rule 10b5-1 trading plan is reported for these transactions, so the exercise and sale on September 16, 2026 are not identified as pre-arranged under such a plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Omer Gal

(Last)(First)(Middle)
3 ARIK EINSTEIN ST.
BUILDING B

(Street)
HERZILYA4659071

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nayax Ltd. [ NYAX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CLO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares09/16/2026M1,500(3)A$21.352(5)20,039D
Ordinary Shares09/16/2026S1,500(4)D$45.1698(6)18,539D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$21.352(2)09/16/2026M(1)1,50008/22/202211/22/2026Ordinary Shares1,500$0500D
Explanation of Responses:
1. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
2. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
3. The shares were acquired upon the exercise of stock options
4. The shares sold were acquired upon the exercise of stock options on the same date
5. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
6. These shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS). The exchange rate in effect on the transaction date was 3.033 ILS to $1.000 .
/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact09/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading